<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Chem Inf Model</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Chem Inf Model</journal-id>
    <journal-id journal-id-type="publisher-id">ci</journal-id>
    <journal-id journal-id-type="coden">jcisd8</journal-id>
    <journal-title-group>
      <journal-title>Journal of Chemical Information and Modeling</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1549-9596</issn>
    <issn pub-type="epub">1549-960X</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">5330305</article-id>
    <article-id pub-id-type="doi">10.1021/acs.jcim.6b00109</article-id>
    <article-categories>
      <subj-group>
        <subject>Application Note</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>bioassayR: Cross-Target Analysis of Small Molecule
Bioactivity</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="ath1">
        <name>
          <surname>Backman</surname>
          <given-names>Tyler
William H.</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath2">
        <name>
          <surname>Girke</surname>
          <given-names>Thomas</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
      </contrib>
      <aff id="aff1">Institute for Integrative
Genome Biology, <institution>University of California,
Riverside</institution>, Riverside, California 92521, <country>United States</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>T. Girke. E-mail: <email>thomas.girke@ucr.edu</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>01</day>
      <month>07</month>
      <year>2016</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <day>25</day>
      <month>07</month>
      <year>2016</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>01</day>
      <month>07</month>
      <year>2017</year>
    </pub-date>
    <volume>56</volume>
    <issue>7</issue>
    <fpage>1237</fpage>
    <lpage>1242</lpage>
    <history>
      <date date-type="received">
        <day>24</day>
        <month>02</month>
        <year>2016</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2016 American Chemical Society</copyright-statement>
      <copyright-year>2016</copyright-year>
      <copyright-holder>American Chemical Society</copyright-holder>
      <license>
        <license-p>This is an open access article published under an ACS AuthorChoice <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci-2016-00109z_0002" id="ab-tgr1"/>
      </p>
      <p>Despite a large and
rapidly growing body of small molecule bioactivity
screens available in the public domain, systematic leverage of the
data to assess target druggability and compound selectivity has been
confounded by a lack of suitable cross-target analysis software. We
have developed bioassayR, a computational tool that enables simultaneous
analysis of thousands of bioassay experiments performed over a diverse
set of compounds and biological targets. Unique features include support
for large-scale cross-target analyses of both public and custom bioassays,
generation of high throughput screening fingerprints (HTSFPs), and
an optional preloaded database that provides access to a substantial
portion of publicly available bioactivity data. bioassayR is implemented
as an open-source R/Bioconductor package available from <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bioconductor.org/packages/bioassayR/">https://bioconductor.org/packages/bioassayR/</uri>.</p>
    </abstract>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>ci6b00109</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>ci-2016-00109z</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>Diverse collections of small molecules
have been screened over
the past decade against a wide array of distinct protein target families.
The resulting high throughout screening (HTS) data are available in
community driven databases such as PubChem Bioassay, ChEMBL, ZINC,
ChemDB, and many others (list in Table S1 of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.6b00109/suppl_file/ci6b00109_si_001.pdf">Supporting Information</ext-link>).<sup><xref ref-type="bibr" rid="ref1">1</xref>−<xref ref-type="bibr" rid="ref4">4</xref></sup> As demonstrated by many data mining efforts, these
bioactivity resources provide an opportunity for studying the selectivity
patterns and molecular mechanisms of small molecule–target
interactions on a broad scale.<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref5">5</xref>−<xref ref-type="bibr" rid="ref11">11</xref></sup> These insights have the potential to lead to the discovery of drug
candidates and protein target sites relevant for medical or chemical
genomics applications. The data can also be used to identify and exclude
drug candidates with largely unselective binding properties (e.g.,
promiscuous binders) that have been found to be of limited use to
most application areas.<sup><xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref13">13</xref></sup> Moreover, the bioactivity data can be used to develop multitarget
treatments specific to one or several cross-connected pathways; to
identify alternative uses for existing drugs; or to predict potential
side and toxic effects.<sup><xref ref-type="bibr" rid="ref14">14</xref>−<xref ref-type="bibr" rid="ref16">16</xref></sup> Data from single target screens
(i.e., a bioassay with a specific target protein) can also be helpful
for prioritizing potential target sites in multiplexed or high-content
screens, where a specific target protein is usually unknown. Furthermore,
large-scale compound bioassay data can be used to create an inventory
of molecular functions and proteins that are accessible or resistant
to perturbations by small molecules. These “druggability profiles”
can be used to guide decision processes in selecting the most efficient
target sites for a specific research application in drug discovery
and other small molecule driven research disciplines.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup></p>
    <p>Most of the small molecule bioactivity data available
in the above-mentioned
public databases were generated by systematic screening efforts of
the Molecular Libraries Program (MLP), the Chemical Biology Program
of the Broad Institute, and a variety of smaller public efforts.<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> The online interfaces of these databases provide
many useful search and download options for focused analysis of a
small number of molecules or target proteins.<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></sup> Although
several projects have developed statistical methods and sample scripts
applicable to cross-target analysis, there is currently no general
purpose software infrastructure available to perform these tasks in
a systematic and fully customizable manner.<sup><xref ref-type="bibr" rid="ref5">5</xref>−<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup></p>
    <p>To address this deficit, we have developed bioassayR, a computational
package for the statistical programming language R that enables simultaneous
analysis of numerous bioassay experiments performed across diverse
compounds and biological targets.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> bioassayR
is distinct from existing tools for analyzing high throughput screening
data in several important ways: (i) its focus on the simultaneous
tracking and comparative analysis of a large number of assays of distinct
experimental design and source; (ii) its flexible data structures
optimized for performance with large data and interoperability with
existing statistical software; (iii) its integration with numerous
R language cheminformatics and bioinformatics tools curated by the
Bioconductor and CRAN projects, including ChemmineR, ChemmineOB, rcdk,
cellHTS, fmcsR, and eiR.<sup><xref ref-type="bibr" rid="ref20">20</xref>−<xref ref-type="bibr" rid="ref26">26</xref></sup> For example, users can analyze their own HTS data (e.g., processed
with cellHTS) alongside public bioactivity data; or process bioactivity
fingerprints (HTSFPs) with functionalities provided by ChemmineR.
HTSFPs summarize the activity of compounds across many protein targets.
Several studies have demonstrated their effectiveness in predicting
and categorizing bioactivity in a manner complementing rather than
overlapping with structure based predictions.<sup><xref ref-type="bibr" rid="ref27">27</xref>−<xref ref-type="bibr" rid="ref33">33</xref></sup> In addition, they can be used as trainings data sets for predicting
active ligand-target pairs with supervised machine learning algorithms.<sup><xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref35">35</xref></sup> The HTSFP tools implemented in bioassayR will generate fingerprints
for any custom set of compounds and targets, optionally merge assays
with similar or identical targets, and compare activity profiles by
either continuous <italic>z</italic>-scores or binary active/inactive
values. The <italic>z</italic>-score based HTSFPs exhibit greater
predictive power in hit expansion experiments, whereas binary HTSFPs
require less computational overhead, enabling all-against-all bioactivity
profile comparison for hundreds of thousands of compounds.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup></p>
  </sec>
  <sec id="sec2">
    <title>Methods and Implementation</title>
    <sec id="sec2.1">
      <title>Software Design
and Workflow Overview</title>
      <p>bioassayR’s
data model is designed around four interconnected data objects (R
language S4 classes), each with an internal structure optimized for
different bioactivity analysis routines. They are introduced below
in more detail, and <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref> provides an illustration. In short, the bioassay data is
organized in an SQL database called <italic>bioassayDB</italic>; data
from single and many assays are imported into <italic>bioassay</italic> and <italic>bioassaySet</italic> objects, respectively; and the
compound–target matrix summarizes the compound vs target activities
from many assays. The <italic>bioassayDB</italic> serves as a large
data repository that can efficiently organize and query millions of
assays simultaneously, whereas the other objects facilitate analysis
of a subset of these data selected to answer a specific biological
question. Table S2 in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.6b00109/suppl_file/ci6b00109_si_001.pdf">Supporting Information</ext-link> lists selected cross-target analysis functions that query the data
within these objects. Users can optionally use a prebuilt <italic>bioassayDB</italic> database that contains publicly available bioactivity
data against a wide range of protein targets.</p>
      <fig id="fig1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Design overview and workflow.
bioassayR stores bioactivity data
in four interconnected objects. (A) Data from a single bioassay experiment
is imported into a bioassay object. (B) Any number of bioassay objects
can be loaded into the <italic>bioassayDB</italic> SQL database that
is optimized for time efficient searching. (C) Filter and query methods
are available to identify compounds or assays of interest. These query
results can be imported into a bioassaySet object that stores activity
data as a sparse matrix where columns represent compounds and rows
assays (targets). This organization facilitates many typical cross-target
analysis routines, e.g., target selectivity analyses. (D) To reduce
both redundancy and sparseness in the data, assays involving the same
or similar targets can be collapsed into a single row using the <italic>perTargetMatrix</italic> function.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci-2016-00109z_0001" id="gr1" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.2">
      <title>bioassay Object: Importing Data</title>
      <p>The <italic>bioassay</italic> object (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref> section
A) stores data from a single bioassay experiment, and acts as a gateway
for importing new assay data, as well as for editing and investigating
data from one assay at a time. This object stores the assay identifier
(aid), data source, assay type, target species, scoring method, target
identifiers, target categories, and activity scores.</p>
      <p>bioassayR
provides users with the option of performing analyses either on their
own bioactivity data, on a prebuilt database of public domain bioactivity
data, or both simultaneously. Four options exist for importing data
as a bioassay object: (i) data in the standard PubChem CSV and XML
formats can be parsed with a built in function; (ii) data already
represented as an R <italic>data.frame</italic> or tabular file with
activity values can be directly converted into a bioassay object;
(iii) raw screening data from a microtiter plate reader can be analyzed
using the cellHTS2 R package, and converted into a bioassay object;
(iv) extracting a single assay from an already existing bioassayR
database, such as the prebuilt PubChem BioAssay database described
below.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> All four options are demonstrated
with examples in the package documentation. Once represented as a
bioassay object, these data can be viewed, edited, or loaded into
a <italic>bioassayDB</italic> database for analysis alongside other
assays.</p>
    </sec>
    <sec id="sec2.3">
      <title>bioassayDB Object: Multiple Assay SQL Database</title>
      <p>The <italic>bioassayDB</italic> object (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref> section B) stores a connection to a SQL database optimized
for efficient aggregate search-based analysis across multiple assays.
Users can load, edit, or delete individual <italic>bioassay</italic> objects, and then query these data. Many analysis and query functions
are provided to investigate the data within a <italic>bioassayDB</italic> object (see Table S2 in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.6b00109/suppl_file/ci6b00109_si_001.pdf">Supporting Information</ext-link>). The database is contained within a single file that can be easily
shared among users. Internally, the database stores data from a large
number of individual bioassay objects, in addition to target protein
domain data, and target identifier mappings. Multiple types of identifier
mapping and annotation data can be stored, for example to translate
target identifiers into those used by common databases such as UniProt,
or to annotate proteins by storing categorization data such as a sequence-similarity
clustering bin for each protein.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup></p>
    </sec>
    <sec id="sec2.4">
      <title>bioassaySet
Object: Storing Multiple Assays in a Matrix</title>
      <p>Query results
from <italic>bioassayDB</italic> can be stored as a <italic>bioassaySet</italic> (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref> section
C). This matrix-like object along with its accessor
methods abstracts complicated analysis tasks across large numbers
of compounds and bioassays. By representing bioactivity data as a
compound vs assay matrix, the full range of matrix operations in R
can be leveraged to analyze these data efficiently. For example, rows
can be compared to compute the similarity between the activity profiles
of two molecules. Sparse matrix compression is utilized to avoid unnecessary
usage of system memory by untested compound–target combinations.
In a typical workflow, a user will first query the database to find
a list of compounds or assays of interest, and then extract these
into a <italic>bioassaySet</italic> for further analysis.</p>
      <p>To
address questions of compound vs target bioactivity, bioassayR can
transform a <italic>bioassaySet</italic> into a compound–target
matrix by merging assays that share common or similar target proteins,
such as close orthologs from different species. Replicates and similar-target
assays can be summarized into single values by either specifying a
custom summary statistic, or choosing among several provided. The
compound vs target matrix can be generated from either discrete “active”
or ”inactive” activity categories, or from continuous
activity scores to serve as either binary or continuous numeric HTSFPs,
respectively. The <italic>scaleBioassaySet</italic> function will
scale and center continuous scores to create a <italic>z</italic>-score
fingerprint. Optionally, omitting inactive values from the discrete
activity categories will produce a matrix suitable for analysis with
binary matrix algorithms. This data structure can serve as a bipartite
graph (or bigraph) connecting compounds and targets, allowing users
to analyze these data with the numerous graph and network analysis
algorithms available for the R programming language.</p>
    </sec>
    <sec id="sec2.5">
      <title>Prebuilt PubChem
BioAssay Database</title>
      <p>To enable efficient
analyses across large numbers of compounds and protein targets, we
provide downloadable instances of the <italic>bioassayDB</italic> database
preloaded with public bioactivity data. This frequently updated database
file includes all screens from PubChem BioAssay involving known target
proteins. PubChem BioAssay data has been chosen since it includes
assays from many sources such as ChEMBL, and therefore represents
a substantial portion of all publicly available bioactivity data.
At the time of this writing the data contains activity results from
roughly 1.2 million structurally distinct compounds tested against
protein 6339 targets. As many compound–target combinations
have not been tested, these data are sparse with roughly half (572 947)
of the compounds having screening results for at least 10 distinct
protein targets. Among these “highly screened” compounds,
895 are currently FDA approved drugs. PubChem BioAssay provides bioactivity
data both as continuous numeric scores, and active/inactive categories.</p>
      <p>To extend the utility of these data, we provide and include within
the prebuilt database additional annotation details for each protein
target. The database includes both NCBI Protein GI numbers and UniProt
identifiers for all protein targets, Pfam domains identified with
the HMMER software, and amino acid sequence similarity-based clustering
performed with kClust.<sup><xref ref-type="bibr" rid="ref36">36</xref>−<xref ref-type="bibr" rid="ref39">39</xref></sup> The UniProt identifiers allow users to obtain further annotation
details including Gene Ontology (GO) terms programmatically by connecting
to external annotation databases.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> The
Pfam domain mappings provide groupings for local similarities and
across wider evolutionary distances, whereas the sequence similarity
cluster are more suitable for identifying groups of sequences sharing
a defined degree of sequence similarity.</p>
      <p>The included annotation
data expand the usefulness of bioassayR
for several applications. For instance, the annotations can be used
for merging similar assays into a compound–target matrix as
described in the above “<xref rid="sec2.4" ref-type="other">bioassaySet Object</xref>” section. When searching for compounds active against a desired
protein, users can expand the search to include compounds found active
against protein targets that share sequence similarity, domains, or
GO terms with the query. This method can identify compounds that are
likely active against a target of interest, even if little or no screening
data exists for that specific target. In drug discovery experiments
where a specific protein target has not yet been identified, these
data can help identify protein targets worth investigating based on
presence of a specific protein domain, molecular function, or orthologue
that has been previously found to be involved in the desired therapeutic
effect.</p>
    </sec>
    <sec id="sec2.6">
      <title>Identifying Compounds with Selective or Promiscuous Bioactivity</title>
      <p>Bioactive small molecules can be classified according to the quantity
of distinct molecular targets they are active against. Target selective
compounds bind to a small number of target proteins, whereas “promiscuous
binders”, indiscriminately bind to a large number of targets.
Patterns of target selectivity in widely used drugs can also be used
as a template for identifying drug candidates with similar selectivity
profiles.</p>
      <p>Several bioassayR functions facilitate identification
of target selective compounds and the reverse, compound selective
targets, across a large set of bioassay experimental results. The <italic>targetSelectivity</italic> function will return the target selectivity
for a query compound. To find compounds active against a target or
a set of targets in a pathway of interest, the function <italic>activeAgainst</italic> will return all active compounds, whereas <italic>selectiveAgainst</italic> will return only compounds most selective against the specified
target, along with a corresponding selectivity score for each. To
consider only compounds that have been tested in numerous assays,
the <italic>screenedAtLeast</italic> function will identify compounds
that have participated in a specified minimum quantity of screens.
To find all targets of a query compound, the functions <italic>activeTargets</italic> and <italic>inactiveTargets</italic> will return the list of active
and inactive targets, respectively. The <italic>crossReactivityProbability</italic> function uses a beta-binomial statistical model to estimate the
probability that a given compound is a promiscuous binder.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup></p>
    </sec>
    <sec id="sec2.7">
      <title>Clustering Small Molecules by Bioactivity
Profile</title>
      <p>With
bioassayR, large-scale screening data can be used to cluster small
molecules based on the similarity of their bioactivity profiles across
many target proteins. To cluster small molecules by bioactivity, it
is necessary to choose an appropriate similarity measure, such as
correlation coefficients that are appropriate for continuous activity
data, and the Jaccard or Tanimoto coefficient for categorical or binary
data.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> Next, the chosen similarity measure
is used to compute a distance matrix (<italic>d</italic>) for all
possible pairwise comparisons of bioactivity profiles, by subtracting
the similarity values (<italic>s</italic>) from one: <italic>d</italic> = 1 – <italic>s</italic>. The distance matrix can then be
used as direct input to a variety of clustering algorithms, including
hierarchical clustering, k-means or multiple dimensional scaling (MDS).</p>
      <p>The bioassayR clustering workflow starts by generating a compound–target
bioactivity matrix, as described above, with either continuous or
discrete category activity scores. For continuous scores, several
similarity functions available in R, such as the base function <italic>cor</italic> can be used to create a distance matrix based on Pearson
correlation coefficients. The associated ChemmineR package will create
a distance matrix for binary bioactivity fingerprints generated by
bioassayR. Comparisons among binary ChemmineR fingerprints have less
CPU and memory overhead than continuous z-score based comparisons,
and therefore are suitable for all-against-all comparisons of larger
compound sets.</p>
      <p>By default, the bioassayR HTSFPs features resolve
missing (untested)
activity values by assuming inactivity, where a “0”
is used for binary fingerprints, and a <italic>z</italic>-score of
“0” is used for continuous fingerprints. When computing
the similarity between two compound bioactivity profiles, this can
lead to false negatives (lower than the true similarity value) if
the compounds share few common screened targets.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> A more accurate estimate of similarity can be obtained
by using machine learning methods that impute the missing values;
however, this introduces false positives that are often less desirable
than false negatives in drug discovery efforts.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> The bioassayR function <italic>screenedAtLeast</italic> can limit false negatives without introducing false positives by
including only highly screened compounds in the analysis. Alternatively,
the compound vs target matrix can be subset with a biclustering algorithm
to limit similarity comparison to a densely screened subset of a larger
sparse compound vs target matrix. Lastly, bioassayR also provides
a similarity function (<italic>trinarySimilarity</italic>) that avoids
assuming inactivity for missing compound–target activity values
by operating on a trinary bioactivity matrix that uses a “0”
for untested or missing values, a “1” for inactive values,
and a “2” for active values. This function computes
similarity based only on the mutually screened targets between two
compounds, and returns an “NA” if insufficient shared
assays exist to make a meaningful comparison. The strategy of performing
the comparison only on mutually screened targets, with a minimum threshold
for informative data was inspired by the continuous score “Assay
Performance Profile Similarity” metric published by Dančík
et al.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup></p>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Results and Discussion</title>
    <p>In the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.6b00109/suppl_file/ci6b00109_si_001.pdf">Supporting Information</ext-link>, we highlight
three example use cases demonstrating the utility of bioassayR. First,
we investigate the diversity of public screening data provided by
PubChem BioAssay, and show that these data contain compounds active
against a large number of novel protein targets that are not currently
accessible with FDA approved drugs. Second, we use bioassayR to cluster
FDA approved drugs by bioactivity profiles as well as molecular structure
to demonstrate that many drugs exhibit distinct bioactivity patterns
that cannot be inferred from structure alone. Third, we demonstrate
how bioassayR can be used to enrich a screening library with active
compounds and how to guide the time-consuming target site identification
processes in high-content screening. The vignette (user manual) of
the package contains additional examples including loading custom
screening data, identifying target selective compounds, and performing
custom database queries.</p>
    <p>It is important to point out that HTS
data are noisy and error
prone due to several causes including experimental noise, and incorrect
annotation. Although public bioactivity databases have implemented
strategies to identify and reduce errors, we caution bioassayR users
to expect some level of error and mis-annotation depending on the
source and type of data used.<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> The impact
of these errors on analysis results can be minimized by incorporating
replicates and confirmatory screening results from different sources
using the bioassayR functions described above. If appropriate, error
can also be reduced by limiting analysis to the subset of public bioactivity
data that has been manually curated and carefully annotated with a
machine readable, nonambiguous structured vocabulary from sources
such as the BioAssay Research Database (BARD).<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref43">43</xref></sup></p>
    <p>The bioassayR package is a flexible computational environment
for
simultaneous analysis of large numbers of high-throughput small molecule
bioactivity screens. By organizing large bioactivity data for rapid
access and manipulation within the R programming language, bioassayR
leverages the substantial breadth of these data as a reference to
identify regions of the genome and proteome accessible to small molecule
probes, elucidate mechanisms of action for bioactive molecules, and
identify off-target effects that currently lead to a high attrition
rate in drug discovery efforts.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> bioassayR
provides features to inform the design and analysis of bioactivity
and drug discovery experiments; for example to build compound libraries
enriched for a desired bioactivity, reducing the search space for
effective drugs, druggable protein targets, and chemical genetic probes.
bioassayR has functions to identify compounds that have demonstrated
activity against targets and pathways of interest, or other targets
with sequence or annotation similarity to targets of interest. To
build drug discovery libraries with reduced chances of off-target
effects, bioassayR will rank compounds for selectivity against a desired
target and exclude compounds that show activity against a large number
of other targets. To identify compounds or combinations of compounds
likely to exhibit a desired polypharmacology (activity against multiple
targets), bioassayR will identify all active compounds among a set
of query targets. To assess the potential druggability of protein
targets, bioassayR will report the quantity and target selectivity
of known active drugs and other compounds. To identify compounds with
activity similar to existing drugs or other compounds with a known
utility, the HTSFP features enable clustering by cross-target activity
profiles. Custom screening data can also be analyzed side-by-side
with public data to study the selectivity profiles among newly identified
actives across numerous targets, or to assess the level of agreement
with any public data that the custom assay replicates.</p>
    <p>In addition
to providing numerous analysis functions, bioassayR
also serves as a bridge to facilitate analysis of large screening
data with other machine learning, statistical inference, network analysis,
and bioinformatics tools. Many of these tools support the output formats
produced by bioassayR with little or no changes. In conclusion, bioassayR
lowers the barrier to address questions related to the target selectivity
of small molecules with large-scale bioactivity data.</p>
  </sec>
</body>
<back>
  <notes id="notes-1" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting Information
is available free of charge on the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org">ACS Publications website</ext-link> at DOI: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/abs/10.1021/acs.jcim.6b00109">10.1021/acs.jcim.6b00109</ext-link>.<list id="silist" list-type="simple"><list-item><p>Table of small
molecule databases, cross-target analysis
functions, use case examples, and a performance evaluation (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.6b00109/suppl_file/ci6b00109_si_001.pdf">PDF</ext-link>).</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci6b00109_si_001.pdf">
        <caption>
          <p>ci6b00109_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="funding-statement" id="notes-2">
    <p>This project
was supported by grants from the National Science Foundation [ABI-0957099]
and the National Institute of Health [U24AG051129].</p>
  </notes>
  <notes notes-type="COI-statement" id="NOTES-d332e466-autogenerated">
    <p>The authors declare no
competing financial interest.</p>
  </notes>
  <glossary id="dl1">
    <def-list>
      <title>Abbreviations</title>
      <def-item>
        <term>HTSFPs</term>
        <def>
          <p>high throughput screening fingerprints</p>
        </def>
      </def-item>
      <def-item>
        <term>HTS</term>
        <def>
          <p>high throughput
screening</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Xiao</surname><given-names>J.</given-names></name>; <name><surname>Suzek</surname><given-names>T. O.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Zhou</surname><given-names>Z.</given-names></name>; <name><surname>Han</surname><given-names>L.</given-names></name>; <name><surname>Karapetyan</surname><given-names>K.</given-names></name>; <name><surname>Dracheva</surname><given-names>S.</given-names></name>; <name><surname>Shoemaker</surname><given-names>B. A.</given-names></name>; <name><surname>Bolton</surname><given-names>E.</given-names></name>; <name><surname>Gindulyte</surname><given-names>A.</given-names></name>; <name><surname>Bryant</surname><given-names>S. H.</given-names></name><article-title>PubChem’s
BioAssay Database</article-title>. <source>Nucleic Acids Res.</source><year>2012</year>, <volume>40</volume>, <fpage>D400</fpage>–<lpage>D412</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr1132</pub-id>.<pub-id pub-id-type="pmid">22140110</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Gaulton</surname><given-names>A.</given-names></name>; <name><surname>Bellis</surname><given-names>L. J.</given-names></name>; <name><surname>Bento</surname><given-names>A. P.</given-names></name>; <name><surname>Chambers</surname><given-names>J.</given-names></name>; <name><surname>Davies</surname><given-names>M.</given-names></name>; <name><surname>Hersey</surname><given-names>A.</given-names></name>; <name><surname>Light</surname><given-names>Y.</given-names></name>; <name><surname>McGlinchey</surname><given-names>S.</given-names></name>; <name><surname>Michalovich</surname><given-names>D.</given-names></name>; <name><surname>Al-Lazikani</surname><given-names>B.</given-names></name>; <name><surname>Overington</surname><given-names>J. P.</given-names></name><article-title>ChEMBL:
a large-scale bioactivity database for drug discovery</article-title>. <source>Nucleic Acids Res.</source><year>2012</year>, <volume>40</volume>, <fpage>D1100</fpage>–<lpage>D1107</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr777</pub-id>.<pub-id pub-id-type="pmid">21948594</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Irwin</surname><given-names>J. J.</given-names></name>; <name><surname>Shoichet</surname><given-names>B. K.</given-names></name><article-title>ZINC-a free database of commercially available compounds
for virtual screening</article-title>. <source>J. Chem. Inf. Model.</source><year>2005</year>, <volume>45</volume>, <fpage>177</fpage>–<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1021/ci049714+</pub-id>.<pub-id pub-id-type="pmid">15667143</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Chen</surname><given-names>J.</given-names></name>; <name><surname>Swamidass</surname><given-names>S. J.</given-names></name>; <name><surname>Dou</surname><given-names>Y.</given-names></name>; <name><surname>Bruand</surname><given-names>J.</given-names></name>; <name><surname>Baldi</surname><given-names>P.</given-names></name><article-title>ChemDB: a
public database of small molecules and related chemoinformatics resources</article-title>. <source>Bioinformatics</source><year>2005</year>, <volume>21</volume>, <fpage>4133</fpage>–<lpage>4139</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bti683</pub-id>.<pub-id pub-id-type="pmid">16174682</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Keiser</surname><given-names>M. J.</given-names></name>; <name><surname>Roth</surname><given-names>B. L.</given-names></name>; <name><surname>Armbruster</surname><given-names>B. N.</given-names></name>; <name><surname>Ernsberger</surname><given-names>P.</given-names></name>; <name><surname>Irwin</surname><given-names>J. J.</given-names></name>; <name><surname>Shoichet</surname><given-names>B. K.</given-names></name><article-title>Relating protein
pharmacology by
ligand chemistry</article-title>. <source>Nat. Biotechnol.</source><year>2007</year>, <volume>25</volume>, <fpage>197</fpage>–<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1038/nbt1284</pub-id>.<pub-id pub-id-type="pmid">17287757</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Yan</surname><given-names>S. F.</given-names></name>; <name><surname>King</surname><given-names>F. J.</given-names></name>; <name><surname>He</surname><given-names>Y.</given-names></name>; <name><surname>Caldwell</surname><given-names>J. S.</given-names></name>; <name><surname>Zhou</surname><given-names>Y.</given-names></name><article-title>Learning from
the Data: Mining of Large High-Throughput Screening Databases</article-title>. <source>J. Chem. Inf. Model.</source><year>2006</year>, <volume>46</volume>, <fpage>2381</fpage>–<lpage>2395</lpage>. <pub-id pub-id-type="doi">10.1021/ci060102u</pub-id>.<pub-id pub-id-type="pmid">17125181</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Wassermann</surname><given-names>A. M.</given-names></name>; <name><surname>Peltason</surname><given-names>L.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name><article-title>Computational Analysis of Multi-target
Structure-Activity Relationships to Derive Preference Orders for Chemical
Modifications toward Target Selectivity</article-title>. <source>ChemMedChem</source><year>2010</year>, <volume>5</volume>, <fpage>847</fpage>–<lpage>858</lpage>. <pub-id pub-id-type="doi">10.1002/cmdc.201000064</pub-id>.<pub-id pub-id-type="pmid">20414918</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Han</surname><given-names>L.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Bryant</surname><given-names>S. H.</given-names></name><article-title>A survey
of across-target bioactivity
results of small molecules in PubChem.</article-title>. <source>Bioinformatics</source><year>2009</year>, <volume>25</volume>, <fpage>2251</fpage>–<lpage>2255</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp380</pub-id>.<pub-id pub-id-type="pmid">19549631</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Cheng</surname><given-names>T.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Bryant</surname><given-names>S. H.</given-names></name><article-title>Investigating
the correlations among
the chemical structures, bioactivity profiles and molecular targets
of small molecules</article-title>. <source>Bioinformatics</source><year>2010</year>, <volume>26</volume>, <fpage>2881</fpage>–<lpage>2888</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq550</pub-id>.<pub-id pub-id-type="pmid">20947527</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Senger</surname><given-names>C.</given-names></name>; <name><surname>Gruning</surname><given-names>B. A.</given-names></name>; <name><surname>Erxleben</surname><given-names>A.</given-names></name>; <name><surname>Doring</surname><given-names>K.</given-names></name>; <name><surname>Patel</surname><given-names>H.</given-names></name>; <name><surname>Flemming</surname><given-names>S.</given-names></name>; <name><surname>Merfort</surname><given-names>I.</given-names></name>; <name><surname>Gunther</surname><given-names>S.</given-names></name><article-title>Mining and evaluation
of molecular relationships in literature</article-title>. <source>Bioinformatics</source><year>2012</year>, <volume>28</volume>, <fpage>709</fpage>–<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bts026</pub-id>.<pub-id pub-id-type="pmid">22247277</pub-id></mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Schurer</surname><given-names>S. C.</given-names></name>; <name><surname>Vempati</surname><given-names>U.</given-names></name>; <name><surname>Smith</surname><given-names>R.</given-names></name>; <name><surname>Southern</surname><given-names>M.</given-names></name>; <name><surname>Lemmon</surname><given-names>V.</given-names></name><article-title>BioAssay Ontology
Annotations Facilitate Cross-Analysis of Diverse High-Throughput Screening
Data Sets</article-title>. <source>J. Biomol. Screening</source><year>2011</year>, <volume>16</volume>, <fpage>415</fpage>–<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1177/1087057111400191</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>McGovern</surname><given-names>S. L.</given-names></name>; <name><surname>Helfand</surname><given-names>B. T.</given-names></name>; <name><surname>Feng</surname><given-names>B.</given-names></name>; <name><surname>Shoichet</surname><given-names>B. K.</given-names></name><article-title>A Specific Mechanism
of Nonspecific Inhibition</article-title>. <source>J. Med. Chem.</source><year>2003</year>, <volume>46</volume>, <fpage>4265</fpage>–<lpage>4272</lpage>. <pub-id pub-id-type="doi">10.1021/jm030266r</pub-id>.<pub-id pub-id-type="pmid">13678405</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Dan
ik</surname><given-names>V.</given-names></name>; <name><surname>Carrel</surname><given-names>H.</given-names></name>; <name><surname>Bodycombe</surname><given-names>N. E.</given-names></name>; <name><surname>Seiler</surname><given-names>K. P.</given-names></name>; <name><surname>Fomina-Yadlin</surname><given-names>D.</given-names></name>; <name><surname>Kubicek</surname><given-names>S. T.</given-names></name>; <name><surname>Hartwell</surname><given-names>K.</given-names></name>; <name><surname>Shamji</surname><given-names>A. F.</given-names></name>; <name><surname>Wagner</surname><given-names>B. K.</given-names></name>; <name><surname>Clemons</surname><given-names>P. A.</given-names></name><article-title>Connecting Small Molecules with Similar Assay Performance
Profiles Leads to New Biological Hypotheses</article-title>. <source>J. Biomol. Screening</source><year>2014</year>, <volume>19</volume>, <fpage>771</fpage>–<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1177/1087057113520226</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Schmidt</surname><given-names>U.</given-names></name>; <name><surname>Struck</surname><given-names>S.</given-names></name>; <name><surname>Gruening</surname><given-names>B.</given-names></name>; <name><surname>Hossbach</surname><given-names>J.</given-names></name>; <name><surname>Jaeger</surname><given-names>I. S.</given-names></name>; <name><surname>Parol</surname><given-names>R.</given-names></name>; <name><surname>Lindequist</surname><given-names>U.</given-names></name>; <name><surname>Teuscher</surname><given-names>E.</given-names></name>; <name><surname>Preissner</surname><given-names>R.</given-names></name><article-title>SuperToxic:
a comprehensive database of toxic compounds</article-title>. <source>Nucleic Acids Res.</source><year>2009</year>, <volume>37</volume>, <fpage>D295</fpage>–<lpage>D299</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkn850</pub-id>.<pub-id pub-id-type="pmid">19004875</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Kuhn</surname><given-names>M.</given-names></name>; <name><surname>Campillos</surname><given-names>M.</given-names></name>; <name><surname>Letunic</surname><given-names>I.</given-names></name>; <name><surname>Jensen</surname><given-names>L. J.</given-names></name>; <name><surname>Bork</surname><given-names>P.</given-names></name><article-title>A side effect
resource to capture phenotypic effects of drugs</article-title>. <source>Mol. Syst. Biol.</source><year>2010</year>, <volume>6</volume>, <fpage>343</fpage><pub-id pub-id-type="doi">10.1038/msb.2009.98</pub-id>.<pub-id pub-id-type="pmid">20087340</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Lounkine</surname><given-names>E.</given-names></name>; <name><surname>Keiser</surname><given-names>M. J.</given-names></name>; <name><surname>Whitebread</surname><given-names>S.</given-names></name>; <name><surname>Mikhailov</surname><given-names>D.</given-names></name>; <name><surname>Hamon</surname><given-names>J.</given-names></name>; <name><surname>Jenkins</surname><given-names>J. L.</given-names></name>; <name><surname>Lavan</surname><given-names>P.</given-names></name>; <name><surname>Weber</surname><given-names>E.</given-names></name>; <name><surname>Doak</surname><given-names>A. K.</given-names></name>; <name><surname>Côté</surname><given-names>S.</given-names></name>; <name><surname>Shoichet</surname><given-names>B. K.</given-names></name>; <name><surname>Urban</surname><given-names>L.</given-names></name><article-title>Large-scale
prediction and testing of drug activity on side-effect targets</article-title>. <source>Nature</source><year>2012</year>, <volume>486</volume>, <fpage>361</fpage>–<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1038/nature11159</pub-id>.<pub-id pub-id-type="pmid">22722194</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Dandapani</surname><given-names>S.</given-names></name>; <name><surname>Marcaurelle</surname><given-names>L. A.</given-names></name><article-title>Grand Challenge Commentary: Accessing new chemical
space for ’undruggable’ targets</article-title>. <source>Nat. Chem. Biol.</source><year>2010</year>, <volume>6</volume>, <fpage>861</fpage>–<lpage>863</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.479</pub-id>.<pub-id pub-id-type="pmid">21079589</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Austin</surname><given-names>C. P.</given-names></name>; <name><surname>Brady</surname><given-names>L. S.</given-names></name>; <name><surname>Insel</surname><given-names>T. R.</given-names></name>; <name><surname>Collins</surname><given-names>F. S.</given-names></name><article-title>NIH Molecular Libraries
Initiative</article-title>. <source>Science</source><year>2004</year>, <volume>306</volume>, <fpage>1138</fpage>–<lpage>1139</lpage>. <pub-id pub-id-type="doi">10.1126/science.1105511</pub-id>.<pub-id pub-id-type="pmid">15542455</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Gedeck</surname><given-names>P.</given-names></name>; <name><surname>Rohde</surname><given-names>B.</given-names></name>; <name><surname>Bartels</surname><given-names>C.</given-names></name><article-title>QSAR - How
Good Is It in Practice?
Comparison of Descriptor Sets on an Unbiased Cross Section of Corporate
Data Sets</article-title>. <source>J. Chem. Inf. Model.</source><year>2006</year>, <volume>46</volume>, <fpage>1924</fpage>–<lpage>1936</lpage>. <pub-id pub-id-type="doi">10.1021/ci050413p</pub-id>.<pub-id pub-id-type="pmid">16995723</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="computer-program" id="cit20"><collab>R Core Team</collab>. <source>R: A Language and Environment
for Statistical Computing</source>; <publisher-name>R Foundation for
Statistical Computing</publisher-name>: <publisher-loc>Vienna, Austria</publisher-loc>, <year>2013</year>.</mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Gentleman</surname><given-names>R. C.</given-names></name>; <name><surname>Carey</surname><given-names>V. J.</given-names></name>; <name><surname>Bates</surname><given-names>D. M.</given-names></name>; <name><surname>Bolstad</surname><given-names>B.</given-names></name>; <name><surname>Dettling</surname><given-names>M.</given-names></name>; <name><surname>Dudoit</surname><given-names>S.</given-names></name>; <name><surname>Ellis</surname><given-names>B.</given-names></name>; <name><surname>Gautier</surname><given-names>L.</given-names></name>; <name><surname>Ge</surname><given-names>Y.</given-names></name>; <name><surname>Gentry</surname><given-names>J.</given-names></name>; <name><surname>Hornik</surname><given-names>K.</given-names></name>; <name><surname>Hothorn</surname><given-names>T.</given-names></name>; <name><surname>Huber</surname><given-names>W.</given-names></name>; <name><surname>Iacus</surname><given-names>S.</given-names></name>; <name><surname>Irizarry</surname><given-names>R.</given-names></name>; <name><surname>Leisch</surname><given-names>F.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Maechler</surname><given-names>M.</given-names></name>; <name><surname>Rossini</surname><given-names>A. J.</given-names></name>; <name><surname>Sawitzki</surname><given-names>G.</given-names></name>; <name><surname>Smith</surname><given-names>C.</given-names></name>; <name><surname>Smyth</surname><given-names>G.</given-names></name>; <name><surname>Tierney</surname><given-names>L.</given-names></name>; <name><surname>Yang</surname><given-names>J. Y. H.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name><article-title>Bioconductor:
open software development for computational biology and bioinformatics</article-title>. <source>Genome Biol.</source><year>2004</year>, <volume>5</volume>, <fpage>R80</fpage><pub-id pub-id-type="doi">10.1186/gb-2004-5-10-r80</pub-id>.<pub-id pub-id-type="pmid">15461798</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Cao</surname><given-names>Y.</given-names></name>; <name><surname>Charisi</surname><given-names>A.</given-names></name>; <name><surname>Cheng</surname><given-names>L. C.</given-names></name>; <name><surname>Jiang</surname><given-names>T.</given-names></name>; <name><surname>Girke</surname><given-names>T.</given-names></name><article-title>ChemmineR:
a compound mining framework for R</article-title>. <source>Bioinformatics</source><year>2008</year>, <volume>24</volume>, <fpage>1733</fpage>–<lpage>1734</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btn307</pub-id>.<pub-id pub-id-type="pmid">18596077</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Guha</surname><given-names>R.</given-names></name><article-title>Chemical Informatics
Functionality in R</article-title>. <source>J. Stat. Softw.</source><year>2007</year>, <volume>18</volume>, <fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.18637/jss.v018.i05</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Cao</surname><given-names>Y.</given-names></name>; <name><surname>Jiang</surname><given-names>T.</given-names></name>; <name><surname>Girke</surname><given-names>T.</given-names></name><article-title>Accelerated
similarity searching
and clustering of large compound sets by geometric embedding and locality
sensitive hashing</article-title>. <source>Bioinformatics</source><year>2010</year>, <volume>26</volume>, <fpage>953</fpage>–<lpage>959</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq067</pub-id>.<pub-id pub-id-type="pmid">20179075</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Backman</surname><given-names>T. W. H.</given-names></name>; <name><surname>Horan</surname><given-names>K.</given-names></name>; <name><surname>Girke</surname><given-names>T.</given-names></name><article-title>fmcsR: mismatch tolerant
maximum common substructure searching in R</article-title>. <source>Bioinformatics</source><year>2013</year>, <volume>29</volume>, <fpage>2792</fpage>–<lpage>2794</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btt475</pub-id>.<pub-id pub-id-type="pmid">23962615</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Boutros</surname><given-names>M.</given-names></name>; <name><surname>Brás</surname><given-names>L. P.</given-names></name>; <name><surname>Huber</surname><given-names>W.</given-names></name><article-title>Analysis of cell-based
RNAi screens</article-title>. <source>Genome Biol.</source><year>2006</year>, <volume>7</volume>, <fpage>R66</fpage><pub-id pub-id-type="doi">10.1186/gb-2006-7-7-r66</pub-id>.<pub-id pub-id-type="pmid">16869968</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Helal</surname><given-names>K. Y.</given-names></name>; <name><surname>Maciejewski</surname><given-names>M.</given-names></name>; <name><surname>Gregori-Puigjané</surname><given-names>E.</given-names></name>; <name><surname>Glick</surname><given-names>M.</given-names></name>; <name><surname>Wassermann</surname><given-names>A. M.</given-names></name><article-title>Public Domain HTS Fingerprints: Design and Evaluation
of Compound Bioactivity Profiles from PubChem’s Bioassay Repository</article-title>. <source>J. Chem. Inf. Model.</source><year>2016</year>, <volume>56</volume>, <fpage>390</fpage>–<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.5b00498</pub-id>.<pub-id pub-id-type="pmid">26898267</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Petrone</surname><given-names>P. M.</given-names></name>; <name><surname>Simms</surname><given-names>B.</given-names></name>; <name><surname>Nigsch</surname><given-names>F.</given-names></name>; <name><surname>Lounkine</surname><given-names>E.</given-names></name>; <name><surname>Kutchukian</surname><given-names>P.</given-names></name>; <name><surname>Cornett</surname><given-names>A.</given-names></name>; <name><surname>Deng</surname><given-names>Z.</given-names></name>; <name><surname>Davies</surname><given-names>J. W.</given-names></name>; <name><surname>Jenkins</surname><given-names>J. L.</given-names></name>; <name><surname>Glick</surname><given-names>M.</given-names></name><article-title>Rethinking Molecular Similarity:
Comparing Compounds on the Basis
of Biological Activity</article-title>. <source>ACS Chem. Biol.</source><year>2012</year>, <volume>7</volume>, <fpage>1399</fpage>–<lpage>1409</lpage>. <pub-id pub-id-type="doi">10.1021/cb3001028</pub-id>.<pub-id pub-id-type="pmid">22594495</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Wassermann</surname><given-names>A. M.</given-names></name>; <name><surname>Lounkine</surname><given-names>E.</given-names></name>; <name><surname>Urban</surname><given-names>L.</given-names></name>; <name><surname>Whitebread</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>S.</given-names></name>; <name><surname>Hughes</surname><given-names>K.</given-names></name>; <name><surname>Guo</surname><given-names>H.</given-names></name>; <name><surname>Kutlina</surname><given-names>E.</given-names></name>; <name><surname>Fekete</surname><given-names>A.</given-names></name>; <name><surname>Klumpp</surname><given-names>M.</given-names></name>; <name><surname>Glick</surname><given-names>M.</given-names></name><article-title>A Screening
Pattern
Recognition Method Finds New and Divergent Targets for Drugs and Natural
Products</article-title>. <source>ACS Chem. Biol.</source><year>2014</year>, <volume>9</volume>, <fpage>1622</fpage>–<lpage>1631</lpage>. <pub-id pub-id-type="doi">10.1021/cb5001839</pub-id>.<pub-id pub-id-type="pmid">24802392</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Riniker</surname><given-names>S.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Jenkins</surname><given-names>J. L.</given-names></name>; <name><surname>Landrum</surname><given-names>G. A.</given-names></name><article-title>Using Information
from Historical High-Throughput Screens to Predict Active Compounds</article-title>. <source>J. Chem. Inf. Model.</source><year>2014</year>, <volume>54</volume>, <fpage>1880</fpage>–<lpage>1891</lpage>. <pub-id pub-id-type="doi">10.1021/ci500190p</pub-id>.<pub-id pub-id-type="pmid">24933016</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Kauvar</surname><given-names>L. M.</given-names></name>; <name><surname>Higgins</surname><given-names>D. L.</given-names></name>; <name><surname>Villar</surname><given-names>H. O.</given-names></name>; <name><surname>Sportsman</surname><given-names>J. R.</given-names></name>; <name><surname>Engqvist-Goldstein</surname><given-names>Å</given-names></name>; <name><surname>Bukar</surname><given-names>R.</given-names></name>; <name><surname>Bauer</surname><given-names>K. E.</given-names></name>; <name><surname>Dilley</surname><given-names>H.</given-names></name>; <name><surname>Rocke</surname><given-names>D. M.</given-names></name><article-title>Predicting ligand binding to proteins
by affinity fingerprinting</article-title>. <source>Chem. Biol. (Oxford,
U. K.)</source><year>1995</year>, <volume>2</volume>, <fpage>107</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1016/1074-5521(95)90283-X</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="journal" id="cit32"><name><surname>Kauvar</surname><given-names>L. M.</given-names></name>; <name><surname>Villar</surname><given-names>H. O.</given-names></name>; <name><surname>Sportsman</surname><given-names>J. R.</given-names></name>; <name><surname>Higgins</surname><given-names>D. L.</given-names></name>; <name><surname>Schmidt</surname><given-names>D. E.</given-names><suffix>Jr</suffix></name><article-title>Protein affinity map of chemical space</article-title>. <source>J. Chromatogr., Biomed. Appl.</source><year>1998</year>, <volume>715</volume>, <fpage>93</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-4347(98)00045-0</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>Fliri</surname><given-names>A. F.</given-names></name>; <name><surname>Loging</surname><given-names>W. T.</given-names></name>; <name><surname>Thadeio</surname><given-names>P. F.</given-names></name>; <name><surname>Volkmann</surname><given-names>R. A.</given-names></name><article-title>Biological spectra
analysis: Linking biological activity profiles to molecular structure</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source><year>2005</year>, <volume>102</volume>, <fpage>261</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0407790101</pub-id>.<pub-id pub-id-type="pmid">15625110</pub-id></mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Lusci</surname><given-names>A.</given-names></name>; <name><surname>Browning</surname><given-names>M.</given-names></name>; <name><surname>Fooshee</surname><given-names>D.</given-names></name>; <name><surname>Swamidass</surname><given-names>J.</given-names></name>; <name><surname>Baldi</surname><given-names>P.</given-names></name><article-title>Accurate and efficient target prediction
using a potency-sensitive
influence-relevance voter</article-title>. <source>J. Cheminf.</source><year>2015</year>, <volume>7</volume>, <fpage>63</fpage><pub-id pub-id-type="doi">10.1186/s13321-015-0110-6</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Soufan</surname><given-names>O.</given-names></name>; <name><surname>Ba-alawi</surname><given-names>W.</given-names></name>; <name><surname>Afeef</surname><given-names>M.</given-names></name>; <name><surname>Essack</surname><given-names>M.</given-names></name>; <name><surname>Rodionov</surname><given-names>V.</given-names></name>; <name><surname>Kalnis</surname><given-names>P.</given-names></name>; <name><surname>Bajic</surname><given-names>V. B.</given-names></name><article-title>Mining
Chemical Activity Status from
High-Throughput Screening Assays</article-title>. <source>PLoS One</source><year>2015</year>, <volume>10</volume>, <fpage>e0144426</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0144426</pub-id>.<pub-id pub-id-type="pmid">26658480</pub-id></mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="journal" id="cit36"><collab>The UniProt Consortium</collab>. <article-title>Reorganizing the
protein space at the Universal Protein Resource (UniProt)</article-title>. <source>Nucleic Acids Res.</source><year>2012</year>, <volume>40</volume>, <fpage>D71</fpage>–<lpage>D75</lpage>; DOI: <pub-id pub-id-type="doi">10.1093/nar/gkr981</pub-id>.<pub-id pub-id-type="pmid">22102590</pub-id></mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="journal" id="cit37"><name><surname>Punta</surname><given-names>M.</given-names></name>; <name><surname>Coggill</surname><given-names>P. C.</given-names></name>; <name><surname>Eberhardt</surname><given-names>R. Y.</given-names></name>; <name><surname>Mistry</surname><given-names>J.</given-names></name>; <name><surname>Tate</surname><given-names>J.</given-names></name>; <name><surname>Boursnell</surname><given-names>C.</given-names></name>; <name><surname>Pang</surname><given-names>N.</given-names></name>; <name><surname>Forslund</surname><given-names>K.</given-names></name>; <name><surname>Ceric</surname><given-names>G.</given-names></name>; <name><surname>Clements</surname><given-names>J.</given-names></name>; <name><surname>Heger</surname><given-names>A.</given-names></name>; <name><surname>Holm</surname><given-names>L.</given-names></name>; <name><surname>Sonnhammer</surname><given-names>E. L. L.</given-names></name>; <name><surname>Eddy</surname><given-names>S. R.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name>; <name><surname>Finn</surname><given-names>R. D.</given-names></name><article-title>The Pfam protein
families database</article-title>. <source>Nucleic Acids Res.</source><year>2012</year>, <volume>40</volume>, <fpage>D290</fpage>–<lpage>D301</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr1065</pub-id>.<pub-id pub-id-type="pmid">22127870</pub-id></mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="journal" id="cit38"><name><surname>Eddy</surname><given-names>S. R.</given-names></name><article-title>A new generation
of homology search tools based on probabilistic inference</article-title>. <source>Genome Inform.</source><year>2009</year>, <volume>23</volume>, <fpage>205</fpage>–<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1142/9781848165632_0019</pub-id>.<pub-id pub-id-type="pmid">20180275</pub-id></mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="journal" id="cit39"><name><surname>Hauser</surname><given-names>M.</given-names></name>; <name><surname>Mayer</surname><given-names>C. E.</given-names></name>; <name><surname>Söding</surname><given-names>J.</given-names></name><article-title>kClust: fast
and sensitive clustering
of large protein sequence databases</article-title>. <source>BMC Bioinf.</source><year>2013</year>, <volume>14</volume>, <fpage>248</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-14-248</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="journal" id="cit40"><collab>The Gene Ontology Consortium</collab>. <article-title>Gene Ontology
Consortium: going forward</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>, <volume>43</volume>, <fpage>D1049</fpage>–<lpage>D1056</lpage>; DOI: <pub-id pub-id-type="doi">10.1093/nar/gku1179</pub-id>.<pub-id pub-id-type="pmid">25428369</pub-id></mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="journal" id="cit41"><name><surname>Holliday</surname><given-names>J.
D.</given-names></name>; <name><surname>Salim</surname><given-names>N.</given-names></name>; <name><surname>Whittle</surname><given-names>M.</given-names></name>; <name><surname>Willett</surname><given-names>P.</given-names></name><article-title>Analysis and Display
of the Size Dependence of Chemical Similarity Coefficients</article-title>. <source>J. Chem. Inf. Comput. Sci.</source><year>2003</year>, <volume>43</volume>, <fpage>819</fpage>–<lpage>828</lpage>. <pub-id pub-id-type="doi">10.1021/ci034001x</pub-id>.<pub-id pub-id-type="pmid">12767139</pub-id></mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Papadatos</surname><given-names>G.</given-names></name>; <name><surname>Gaulton</surname><given-names>A.</given-names></name>; <name><surname>Hersey</surname><given-names>A.</given-names></name>; <name><surname>Overington</surname><given-names>J. P.</given-names></name><article-title>Activity,
assay and target data curation and quality in the ChEMBL database</article-title>. <source>J. Comput.-Aided Mol. Des.</source><year>2015</year>, <volume>29</volume>, <fpage>885</fpage>–<lpage>896</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-015-9860-5</pub-id>.<pub-id pub-id-type="pmid">26201396</pub-id></mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="journal" id="cit43"><name><surname>Howe</surname><given-names>E. A.</given-names></name>; <name><surname>de Souza</surname><given-names>A.</given-names></name>; <name><surname>Lahr</surname><given-names>D. L.</given-names></name>; <name><surname>Chatwin</surname><given-names>S.</given-names></name>; <name><surname>Montgomery</surname><given-names>P.</given-names></name>; <name><surname>Alexander</surname><given-names>B. R.</given-names></name>; <name><surname>Nguyen</surname><given-names>D.-T.</given-names></name>; <name><surname>Cruz</surname><given-names>Y.</given-names></name>; <name><surname>Stonich</surname><given-names>D. A.</given-names></name>; <name><surname>Walzer</surname><given-names>G.</given-names></name>; <name><surname>Rose</surname><given-names>J. T.</given-names></name>; <name><surname>Picard</surname><given-names>S. C.</given-names></name>; <name><surname>Liu</surname><given-names>Z.</given-names></name>; <name><surname>Rose</surname><given-names>J. N.</given-names></name>; <name><surname>Xiang</surname><given-names>X.</given-names></name>; <name><surname>Asiedu</surname><given-names>J.</given-names></name>; <name><surname>Durkin</surname><given-names>D.</given-names></name>; <name><surname>Levine</surname><given-names>J.</given-names></name>; <name><surname>Yang</surname><given-names>J. J.</given-names></name>; <name><surname>Schurer</surname><given-names>S. C.</given-names></name>; <name><surname>Braisted</surname><given-names>J. C.</given-names></name>; <name><surname>Southall</surname><given-names>N.</given-names></name>; <name><surname>Southern</surname><given-names>M. R.</given-names></name>; <name><surname>Chung</surname><given-names>T. D. Y.</given-names></name>; <name><surname>Brudz</surname><given-names>S.</given-names></name>; <name><surname>Tanega</surname><given-names>C.</given-names></name>; <name><surname>Schreiber</surname><given-names>S. L.</given-names></name>; <name><surname>Bittker</surname><given-names>J. A.</given-names></name>; <name><surname>Guha</surname><given-names>R.</given-names></name>; <name><surname>Clemons</surname><given-names>P. A.</given-names></name><article-title>BioAssay
Research Database (BARD): chemical biology
and probe-development enabled by structured metadata and result types</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>, <volume>43</volume>, <fpage>D1163</fpage>–<lpage>D1170</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku1244</pub-id>.<pub-id pub-id-type="pmid">25477388</pub-id></mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Bowes</surname><given-names>J.</given-names></name>; <name><surname>Brown</surname><given-names>A. J.</given-names></name>; <name><surname>Hamon</surname><given-names>J.</given-names></name>; <name><surname>Jarolimek</surname><given-names>W.</given-names></name>; <name><surname>Sridhar</surname><given-names>A.</given-names></name>; <name><surname>Waldron</surname><given-names>G.</given-names></name>; <name><surname>Whitebread</surname><given-names>S.</given-names></name><article-title>Reducing safety-related
drug attrition: the use of in vitro pharmacological profiling</article-title>. <source>Nat. Rev. Drug Discovery</source><year>2012</year>, <volume>11</volume>, <fpage>909</fpage>–<lpage>922</lpage>. <pub-id pub-id-type="doi">10.1038/nrd3845</pub-id>.<pub-id pub-id-type="pmid">23197038</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
